215 related articles for article (PubMed ID: 37571390)
21. Effectiveness of weight loss interventions in breast cancer survivors: a systematic review of reviews.
Lake B; Damery S; Jolly K
BMJ Open; 2022 Oct; 12(10):e062288. PubMed ID: 36207046
[TBL] [Abstract][Full Text] [Related]
22. The effects of separate and combined dietary weight loss and exercise on fasting ghrelin concentrations in overweight and obese women: a randomized controlled trial.
Mason C; Xiao L; Imayama I; Duggan CR; Campbell KL; Kong A; Wang CY; Alfano CM; Blackburn GL; Foster-Schubert KE; McTiernan A
Clin Endocrinol (Oxf); 2015 Mar; 82(3):369-76. PubMed ID: 24796864
[TBL] [Abstract][Full Text] [Related]
23. Exercise improves adiposopathy, insulin sensitivity and metabolic syndrome severity independent of intensity.
Heiston EM; Eichner NZ; Gilbertson NM; Malin SK
Exp Physiol; 2020 Apr; 105(4):632-640. PubMed ID: 32020676
[TBL] [Abstract][Full Text] [Related]
24. Exercise-Induced Dose-Response Alterations in Adiponectin and Leptin Levels Are Dependent on Body Fat Changes in Women at Risk for Breast Cancer.
Sturgeon K; Digiovanni L; Good J; Salvatore D; Fenderson D; Domchek S; Stopfer J; Galantino ML; Bryan C; Hwang WT; Schmitz K
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1195-200. PubMed ID: 27197293
[TBL] [Abstract][Full Text] [Related]
25. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women.
Ryan AS; Nicklas BJ; Berman DM; Elahi D
Int J Obes Relat Metab Disord; 2003 Sep; 27(9):1066-71. PubMed ID: 12917712
[TBL] [Abstract][Full Text] [Related]
26. Daughters and Mothers Against Breast Cancer (DAMES): main outcomes of a randomized controlled trial of weight loss in overweight mothers with breast cancer and their overweight daughters.
Demark-Wahnefried W; Jones LW; Snyder DC; Sloane RJ; Kimmick GG; Hughes DC; Badr HJ; Miller PE; Burke LE; Lipkus IM
Cancer; 2014 Aug; 120(16):2522-34. PubMed ID: 24804802
[TBL] [Abstract][Full Text] [Related]
27. Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity.
Weiss EP; Reeds DN; Ezekiel UR; Albert SG; Villareal DT
Endocrine; 2017 Jan; 55(1):153-164. PubMed ID: 27605038
[TBL] [Abstract][Full Text] [Related]
28. Strategic recruitment of an ethnically diverse cohort of overweight survivors of breast cancer with lymphedema.
Sturgeon KM; Hackley R; Fornash A; Dean LT; Laudermilk M; Brown JC; Sarwer DB; DeMichele AM; Troxel AB; Schmitz KH
Cancer; 2018 Jan; 124(1):95-104. PubMed ID: 28881471
[TBL] [Abstract][Full Text] [Related]
29. The effect of weight loss magnitude on pro-/anti-inflammatory adipokines and carotid intima-media thickness in obese adolescents engaged in interdisciplinary weight loss therapy.
Masquio DC; de Piano A; Sanches PL; Corgosinho FC; Campos RM; Carnier J; da Silva PL; Caranti DA; Tock L; Oyama LM; Oller do Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Clin Endocrinol (Oxf); 2013 Jul; 79(1):55-64. PubMed ID: 22809141
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity.
Campbell KL; Van Patten CL; Neil SE; Kirkham AA; Gotay CC; Gelmon KA; McKenzie DC
J Acad Nutr Diet; 2012 Apr; 112(4):559-67. PubMed ID: 22709706
[TBL] [Abstract][Full Text] [Related]
31. An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research.
Linkov F; Burke LE; Komaroff M; Edwards RP; Lokshin A; Styn MA; Tseytlin E; Freese KE; Bovbjerg DH
Gynecol Oncol; 2014 Apr; 133(1):67-72. PubMed ID: 24462731
[TBL] [Abstract][Full Text] [Related]
32. Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese.
Rock CL; Pande C; Flatt SW; Ying C; Pakiz B; Parker BA; Williams K; Bardwell WA; Heath DD; Nichols JF
Clin Breast Cancer; 2013 Jun; 13(3):188-95. PubMed ID: 23375717
[TBL] [Abstract][Full Text] [Related]
33. The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote.
Sheng JY; Santa-Maria CA; Blackford AL; Lim D; Carpenter A; Smith KL; Cohen GI; Coughlin J; Appel LJ; Stearns V; Snyder C
J Cancer Surviv; 2022 Jun; 16(3):542-551. PubMed ID: 34018096
[TBL] [Abstract][Full Text] [Related]
34. The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial.
Santa-Maria CA; Coughlin JW; Sharma D; Armanios M; Blackford AL; Schreyer C; Dalcin A; Carpenter A; Jerome GJ; Armstrong DK; Chaudhry M; Cohen GI; Connolly RM; Fetting J; Miller RS; Smith KL; Snyder C; Wolfe A; Wolff AC; Huang CY; Appel LJ; Stearns V
Clin Cancer Res; 2020 Jun; 26(12):3024-3034. PubMed ID: 32071117
[TBL] [Abstract][Full Text] [Related]
35. Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors.
Patterson RE; Marinac CR; Natarajan L; Hartman SJ; Cadmus-Bertram L; Flatt SW; Li H; Parker B; Oratowski-Coleman J; Villaseñor A; Godbole S; Kerr J
Contemp Clin Trials; 2016 Mar; 47():64-71. PubMed ID: 26706665
[TBL] [Abstract][Full Text] [Related]
36. Effect of Weight Loss with or without Exercise on Inflammatory Markers and Adipokines in Postmenopausal Women: The SHAPE-2 Trial, A Randomized Controlled Trial.
van Gemert WA; May AM; Schuit AJ; Oosterhof BY; Peeters PH; Monninkhof EM
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):799-806. PubMed ID: 26908432
[TBL] [Abstract][Full Text] [Related]
37. Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials.
Johansson H; Bellerba F; Macis D; Bertelsen BE; Guerrieri-Gonzaga A; Aristarco V; Viste K; Mellgren G; Di Cola G; Costantino J; Scalbert A; Sears DD; Gandini S; DeCensi A; Bonanni B
Breast Cancer Res Treat; 2024 May; 205(1):49-59. PubMed ID: 38279016
[TBL] [Abstract][Full Text] [Related]
38. Effects of synbiotic supplementation on serum adiponectin and inflammation status of overweight and obese breast cancer survivors: a randomized, triple-blind, placebo-controlled trial.
Raji Lahiji M; Zarrati M; Najafi S; Yazdani B; Cheshmazar E; Razmpoosh E; Janani L; Raji Lahiji M; Shidfar F
Support Care Cancer; 2021 Jul; 29(7):4147-4157. PubMed ID: 33404812
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Circulating MicroRNAs and Adipokines in Breast Cancer Survivors with Arm Lymphedema.
Yusof KM; Groen K; Rosli R; Abdullah M; Mahmud R; Avery-Kiejda KA
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232660
[TBL] [Abstract][Full Text] [Related]
40. Leptin, adiponectin, and their ratio as markers of insulin resistance and cardiometabolic risk in childhood obesity.
Frithioff-Bøjsøe C; Lund MAV; Lausten-Thomsen U; Hedley PL; Pedersen O; Christiansen M; Baker JL; Hansen T; Holm JC
Pediatr Diabetes; 2020 Mar; 21(2):194-202. PubMed ID: 31845423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
